MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Orthofix Medical Gross Profit 2011-2026 | OFIX
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 566 M | 546 M | 486 M | 337 M | 350 M | 305 M | 359 M | 356 M | 341 M | 322 M | 310 M | 303 M | 298 M | 376 M | 440 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 566 M | 298 M | 380 M |
Quarterly Gross Profit Orthofix Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 149 M | 140 M | 122 M | - | 135 M | 135 M | 127 M | - | 120 M | 120 M | 110 M | - | 83.4 M | 86.5 M | 78.1 M | - | 84.1 M | 94 M | 79.7 M | - | 84.7 M | 50 M | 81.4 M | 95.3 M | 88.6 M | 90 M | 85.4 M | 95.5 M | 87.7 M | 88.7 M | 84.6 M | 93.3 M | 81.5 M | 85.8 M | 80.2 M | 85.2 M | 78.6 M | 81.6 M | 76.5 M | 83.2 M | 77.3 M | 79 M | 70.4 M | 78.8 M | 75.7 M | 75.6 M | 73.2 M | 71.8 M | 66.7 M | 75.8 M | 76.4 M | 88.9 M | 80.9 M | 86.7 M | 83 M | 91.3 M | 88.4 M | 85.5 M | 81.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 149 M | 50 M | 89.8 M |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
33 M | $ 3.72 | 0.95 % | $ 153 M |  USA |
 |
Butterfly Network
BFLY
|
48.8 M | $ 4.12 | 0.12 % | $ 872 M | USA |
 |
Bruker Corporation
BRKR
|
1.65 B | $ 36.6 | -0.44 % | $ 5.45 K | USA |
 |
Boston Scientific Corporation
BSX
|
13.9 B | $ 62.34 | -0.76 % | $ 92.3 B | USA |
 |
AdaptHealth Corp.
AHCO
|
89.3 M | $ 12.24 | 1.75 % | $ 1.65 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
67.9 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
42.4 M | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
22.7 M | $ 9.37 | - | $ 265 M | USA |
 |
CONMED Corporation
CNMD
|
750 M | $ 34.21 | -1.67 % | $ 1.06 B | USA |
 |
Acutus Medical
AFIB
|
-3.14 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
2 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
198 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
6.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
443 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
584 K | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
26.5 M | $ 0.63 | 7.41 % | $ 39.2 M | USA |
 |
Delcath Systems
DCTH
|
73.4 M | $ 9.76 | 1.35 % | $ 350 M | USA |
 |
BioSig Technologies
BSGM
|
229 K | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
24.4 M | $ 3.48 | 2.66 % | $ 130 M |  France |
 |
Edwards Lifesciences Corporation
EW
|
4.73 B | $ 81.03 | -0.02 % | $ 47.4 B | USA |
 |
Cardiovascular Systems
CSII
|
173 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-12.7 M | - | -10.19 % | $ 1.99 M | USA |
 |
FONAR Corporation
FONR
|
42.4 M | $ 18.59 | - | $ 122 M | USA |
 |
AxoGen
AXGN
|
167 M | $ 32.72 | -4.99 % | $ 1.51 B | USA |
 |
CryoLife, Inc.
CRY
|
168 M | - | -4.14 % | $ 702 M | USA |
 |
Helius Medical Technologies
HSDT
|
61 K | $ 1.96 | 5.38 % | $ 1.19 M | USA |
 |
Dynatronics Corporation
DYNT
|
6.01 M | - | 14.99 % | $ 929 K | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
953 M | $ 9.3 | -2.41 % | $ 716 M | USA |
 |
Align Technology
ALGN
|
2.8 B | $ 170.69 | 0.05 % | $ 12.8 B | USA |
 |
Eargo
EAR
|
14.3 M | - | - | $ 10.2 M | USA |
 |
Inogen
INGN
|
154 M | $ 6.41 | 3.22 % | $ 171 M | USA |
 |
IRIDEX Corporation
IRIX
|
19.2 M | $ 0.99 | 1.0 % | $ 16.8 M | USA |
 |
IRadimed Corporation
IRMD
|
64.3 M | $ 96.2 | -0.04 % | $ 1.22 B | USA |
 |
Integer Holdings Corporation
ITGR
|
500 M | $ 84.91 | -2.23 % | $ 2.95 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
173 M | $ 15.94 | -0.75 % | $ 374 M | USA |
 |
Conformis
CFMS
|
23.2 M | - | - | $ 16.4 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
28.7 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
43.7 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
1.99 M | - | - | $ 111 M |  Canada |
 |
LENSAR
LNSR
|
14.1 M | $ 5.87 | -3.22 % | $ 70.2 M | USA |
 |
Second Sight Medical Products
EYES
|
500 K | - | -0.97 % | $ 54.4 M | USA |
 |
Pulmonx Corporation
LUNG
|
67.1 M | $ 1.38 | 3.76 % | $ 56.1 M | USA |
 |
Medtronic PLC
MDT
|
19.6 B | $ 86.52 | -0.13 % | $ 111 B | USA |
 |
MiMedx Group
MDXG
|
346 M | $ 3.9 | -0.64 % | $ 576 M | USA |
 |
Intersect ENT, Inc.
XENT
|
50.2 M | - | - | $ 955 M | USA |
 |
Myomo
MYO
|
26.9 M | $ 0.69 | 2.43 % | $ 28.9 M | USA |